Works matching AU Chinot, Olivier L.

Results: 17
    1

    Olaparib in recurrent isocitrate dehydrogenase mutant high-grade glioma: A phase 2 multicenter study of the POLA Network.

    Published in:
    Neuro-Oncology Advances, 2024, v. 6, n. 1, p. 1, doi. 10.1093/noajnl/vdae078
    By:
    • Vazquez, Ines Esparragosa;
    • Sanson, Marc;
    • Chinot, Olivier L;
    • Fontanilles, Maxime;
    • Rivoirard, Romain;
    • Thomas-Maisonneuve, Laure;
    • Cartalat, Stéphanie;
    • Tabouret, Emeline;
    • Appay, Romain;
    • Bonneville-Levard, Alice;
    • Darlix, Amélie;
    • Meyronet, David;
    • Barritault, Marc;
    • Gueyffier, François;
    • Remontet, Laurent;
    • Maucort-Boulch, Delphine;
    • Honnorat, Jérôme;
    • Dehais, Caroline;
    • Ducray, François;
    • Network, POLA
    Publication type:
    Article
    2

    Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations.

    Published in:
    Acta Neuropathologica, 2021, v. 141, n. 6, p. 945, doi. 10.1007/s00401-021-02291-6
    By:
    • Tesileanu, C. Mircea S.;
    • Vallentgoed, Wies R.;
    • Sanson, Marc;
    • Taal, Walter;
    • Clement, Paul M.;
    • Wick, Wolfgang;
    • Brandes, Alba Ariela;
    • Baurain, Jean Francais;
    • Chinot, Olivier L.;
    • Wheeler, Helen;
    • Gill, Sanjeev;
    • Griffin, Matthew;
    • Rogers, Leland;
    • Rudà, Roberta;
    • Weller, Michael;
    • McBain, Catherine;
    • Reijneveld, Jaap;
    • Enting, Roelien H.;
    • Caparrotti, Francesca;
    • Lesimple, Thierry
    Publication type:
    Article
    3

    Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma.

    Published in:
    Neuro-Oncology, 2021, v. 23, n. 9, p. 1547, doi. 10.1093/neuonc/noab088
    By:
    • Tesileanu, C Mircea S;
    • Bent, Martin J van den;
    • Sanson, Marc;
    • Wick, Wolfgang;
    • Brandes, Alba A;
    • Clement, Paul M;
    • Erridge, Sara C;
    • Vogelbaum, Michael A;
    • Nowak, Anna K;
    • Baurain, Jean F;
    • Mason, Warren P;
    • Wheeler, Helen;
    • Chinot, Olivier L;
    • Gill, Sanjeev;
    • Griffin, Matthew;
    • Rogers, Leland;
    • Taal, Walter;
    • Rudà, Roberta;
    • Weller, Michael;
    • McBain, Catherine
    Publication type:
    Article
    4

    A genome-wide association study identifies susceptibility loci for primary central nervous system lymphoma at 6p25.3 and 3p22.1: a LOC Network study.

    Published in:
    Neuro-Oncology, 2019, v. 21, n. 8, p. 1039, doi. 10.1093/neuonc/noz088
    By:
    • Labreche, Karim;
    • Daniau, Mailys;
    • Sud, Amit;
    • Law, Philip J;
    • Royer-Perron, Louis;
    • Holroyd, Amy;
    • Broderick, Peter;
    • Went, Molly;
    • Benazra, Marion;
    • Ahle, Guido;
    • Soubeyran, Pierre;
    • Taillandier, Luc;
    • Chinot, Olivier L;
    • Casasnovas, Olivier;
    • Bay, Jacques-Olivier;
    • Jardin, Fabrice;
    • Oberic, Lucie;
    • Fabbro, Michel;
    • Damaj, Gandhi;
    • Brion, Annie
    Publication type:
    Article
    5

    Radiologic progression of glioblastoma under therapy--an exploratory analysis of AVAglio.

    Published in:
    Neuro-Oncology, 2018, v. 20, n. 4, p. 557, doi. 10.1093/neuonc/nox162
    By:
    • Nowosielski, Martha;
    • Ellingson, Benjamin M.;
    • Chinot, Olivier L.;
    • Garcia, Josep;
    • Revil, Cedric;
    • Radbruch, Alexander;
    • Nishikawa, Ryo;
    • Mason, Warren P.;
    • Henriksson, Roger;
    • Saran, Frank;
    • Kickingereder, Philipp;
    • Platten, Michael;
    • Sandmann, Thomas;
    • Abrey, Lauren E.;
    • Cloughesy, Timothy F.;
    • Bendszus, Martin;
    • Wick, Wolfgang
    Publication type:
    Article
    6
    7
    8
    9
    10
    11

    Understanding the quality of life (QOL) issues in survivors of cancer: towards the development of an EORTC QOL cancer survivorship questionnaire.

    Published in:
    2018
    By:
    • van Leeuwen, Marieke;
    • Husson, Olga;
    • Alberti, Paola;
    • Arraras, Juan Ignacio;
    • Chinot, Olivier L.;
    • Costantini, Anna;
    • Darlington, Anne-Sophie;
    • Dirven, Linda;
    • Eichler, Martin;
    • Hammerlid, Eva B.;
    • Holzner, Bernhard;
    • Johnson, Colin D.;
    • Kontogianni, Meropi;
    • Kjær, Trille Kristina;
    • Morag, Ofir;
    • Nolte, Sandra;
    • Nordin, Andrew;
    • Pace, Andrea;
    • Pinto, Monica;
    • Polz, Katja
    Publication type:
    journal article
    12
    13
    14

    Author reply.

    Published in:
    Cancer (0008543X), 2004, v. 101, n. 12, p. 2898, doi. 10.1002/cncr.20708
    By:
    • Olivier-L Chinot
    Publication type:
    Article
    15
    16
    17

    Temozolomide Plus Bevacizumab in Elderly Patients with Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial (ATAG).

    Published in:
    Oncologist, 2018, v. 23, n. 5, p. 524, doi. 10.1634/theoncologist.2017-0689
    By:
    • Reyes‐Botero, Germán;
    • Cartalat‐Carel, Stéphanie;
    • Chinot, Olivier L.;
    • Barrie, Maryline;
    • Taillandier, Luc;
    • Beauchesne, Patrick;
    • Catry‐Thomas, Isabelle;
    • Barrière, Jérôme;
    • Guillamo, Jean‐Sebastien;
    • Fabbro, Michel;
    • Frappaz, Didier;
    • Benouaich‐Amiel, Alexandra;
    • Le Rhun, Emilie;
    • Campello, Chantal;
    • Tennevet, Isabelle;
    • Ghiringhelli, François;
    • Tanguy, Marie‐Laure;
    • Mokhtari, Karima;
    • Honnorat, Jérôme;
    • Delattre, Jean‐Yves
    Publication type:
    Article